“Molecular Docking study, and In vitro Evaluation of Antitumor Activity of Some New Isoxazoline and Pyrazoline Derivatives of Nabumetone against breast cancer cell line (MCF-7)” (2022) Al Mustansiriyah Journal of Pharmaceutical Sciences, 22(3), pp. 24–34. doi:10.32947/ajps.v22i3.886.